109 related articles for article (PubMed ID: 10694810)
21. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
22. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
Buchholz CJ; Cichutek K
J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
[TBL] [Abstract][Full Text] [Related]
23. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
Patience C; Takeuchi Y; Cosset FL; Weiss RA
J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
25. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
Harries M; Phillipps N; Anderson R; Prentice G; Collins M
J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
[TBL] [Abstract][Full Text] [Related]
26. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
Alfa RW; Blesch A
Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
[TBL] [Abstract][Full Text] [Related]
27. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
Curran MA; Kaiser SM; Achacoso PL; Nolan GP
Mol Ther; 2000 Jan; 1(1):31-8. PubMed ID: 10933909
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
29. From retroviral vector production to gene transfer: spontaneous inactivation is caused by loss of reverse transcription capacity.
Carmo M; Panet A; Carrondo MJ; Alves PM; Cruz PE
J Gene Med; 2008 Apr; 10(4):383-91. PubMed ID: 18240154
[TBL] [Abstract][Full Text] [Related]
30. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
31. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
[TBL] [Abstract][Full Text] [Related]
32. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
Torrent C; Gabus C; Darlix JL
J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
[TBL] [Abstract][Full Text] [Related]
33. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
Kim S; Park EJ; Yu SS; Kim S
J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
[TBL] [Abstract][Full Text] [Related]
34. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
35. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.
Abudu A; Takaori-Kondo A; Izumi T; Shirakawa K; Kobayashi M; Sasada A; Fukunaga K; Uchiyama T
Curr Biol; 2006 Aug; 16(15):1565-70. PubMed ID: 16890533
[TBL] [Abstract][Full Text] [Related]
36. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
37. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
[TBL] [Abstract][Full Text] [Related]
38. Protection of MLV vector particles from human complement.
Breun S; Salmons B; Günzburg WH; Baumann JG
Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
[TBL] [Abstract][Full Text] [Related]
39. Growth factor enhanced retroviral gene transfer to the adult central nervous system.
King LA; Mitrophanous KA; Clark LA; Kim VN; Rohll JB; Kingsman AJ; Colello RJ
Gene Ther; 2000 Jul; 7(13):1103-11. PubMed ID: 10918476
[TBL] [Abstract][Full Text] [Related]
40. Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines.
Guesdon FM; Greatorex J; Rhee SR; Fisher R; Hunter E; Lever AM
Virology; 2001 Sep; 288(1):81-8. PubMed ID: 11543660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
